Sophie Fagg (@SFagg_ER) header
Sophie Fagg (@SFagg_ER) profile picture

Sophie Fagg

@SFagg_ER

Commissioning Editor at Taylor & Francis | Expert Review of Anticancer Therapy | Expert Review of Respiratory Medicine | All views expressed are my own.

 London, UK
informahealthcare.com
Joined September 2013
  • Tweets418
  • Following1.4K
  • Followers430
109Media
Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)Photo by Sophie Fagg (@SFagg_ER)
Checkpoint inhibitors in advanced melanoma bit.ly/2eRd6O6 #ESMO2017 #HotTopic
Postoperative stereotactic radiosurgery for limited brain metastases: are we ready for prime time? bit.ly/2fcTiW0 #ESMO2017
Olaratumab for the treatment of advanced soft tissue sarcoma bit.ly/2xqLSZQ #ESMO2017 #Sarcoma
Improving postoperative radiotherapy following radical prostatectomy bit.ly/2eZEo8F #OpenAccess
Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer bit.ly/2xqNnap #prostate #ESMO2017
Expert Review of Anticancer Therapy welcomes unsolicited content - submit yours today! mc.manuscriptcentral.com/ert #ESMO2017
1
Hepatocellular carcinoma discussion at #ESMO2017 later today! Read our review on proton beam therapy for HCC! bit.ly/2ite1c7
A lot of discussion surrounding melanoma treatments at #esmo2017. Take a look at our recent article on Binimetinib bit.ly/2xqffvo
Proton beam therapy for hepatocellular carcinoma bit.ly/2ite1c7
Reviewing the use of #Nivolumab for the treatment of #melanoma - new article now online: bit.ly/2eS9SZ2
New FREE Editorial: Paul Huang from @ICR_London discusses using TKI therapy to target SWI/SNF mutant cancers bit.ly/2fkvSwl
1
2
3
Special considerations in managing elderly and unfit patients with chronic lymphocytic #leukemia bit.ly/2fzMTph #hematology

Management of elderly and unfit patients with chronic lymphocytic leukemia

Introduction: About 75% of patients with chronic lymphocytic leukemia (CLL) are more than 65 years at the time of diagnosis. Treatment of the elderly remains complicated due to multiple factors, su...

tandfonline.com
Is #Betrixaban the next direct factor Xa inhibitor? Peter Bramlage reviews the evidence: bit.ly/2eJjVBU #hematology
New supplement on guiding decision-making for main treatment options of surgery, chemotherapy and targeted therapy for ovarian cancer teapawt.net/ERJournals/status/7954…
New challenges for hematologists: #MDS and acute #leukemia with genetic predispositions, new review now online: bit.ly/2fPUK33

Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for...

Introduction: The determination of an underlying genetic predisposition is not automatically part of the diagnosis of hematological malignancies (HM) in routine practice. However, it is assumed tha...

tandfonline.com
#FREE Access to October issue of Precision Med & Drug Development until end of November! bit.ly/1SZnPQF #PersonalizedMedicine
Expert Review of Precision Medicine and Drug Development

Expert Review of Precision Medicine and Drug Development

Volume 10, Issue 1 of Expert Review of Precision Medicine and Drug Development

tandfonline.com
11
1
Access to October Issue of QoL in Cancer Care #FREE until the end of November! bit.ly/2f4Bkr9 #Cancer #CancerCare #QoL #palliative
8
1
1
When to use immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma? bit.ly/2e1B4JK

Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them

Published in Expert Review of Hematology (Vol. 9, No. 11, 2016)

tandfonline.com
#Lenvatinib for treatment of radioiodine-refractory differentiated thyroid carcinoma: Pawel Kawalec et al reviews: bit.ly/2e9Xs0g
Tackling relative anemia in sickle cell disease in sub-Saharan Africa, new review from Michael DeBaun: bit.ly/2em8Bss #sicklecell

Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan...

Introduction: Sickle cell disease (SCD) is the most common inherited hemoglobinopathy in the world, with the majority of cases in sub-Saharan Africa. Concomitant nutritional deficiencies, infection...

tandfonline.com
1
Load more